| |
| |
|
| Insider
Information: |
Delong Mark Jeffrey |
| Relationship: |
Chief Business & Strat... |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
54,693 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,669,565 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
54,693 |
|
|
| Total
Value |
$2,669,565 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apellis Pharmaceuticals Inc |
APLS |
Chief Business & Strat... |
2024-03-18 |
54,693 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APLS |
Apellis Pharmaceuticals I... |
Chief Business & Strat Officer |
• • – |
2024-03-18 |
4 |
S |
$56.90 |
$564,050 |
D/D |
(9,913) |
54,693 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Business & Strat Officer |
• • – |
2024-02-12 |
4 |
S |
$67.77 |
$40,457 |
D/D |
(597) |
64,606 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Business & Strat Officer |
• • – |
2024-01-29 |
4 |
S |
$64.14 |
$23,539 |
D/D |
(367) |
65,203 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Business & Strat Officer |
• • – |
2024-01-22 |
4 |
S |
$65.00 |
$89,954 |
D/D |
(1,384) |
65,570 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Business & Strat Officer |
• • – |
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
16,963 |
68,585 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Business & Strat Officer |
• • – |
2024-01-16 |
4 |
S |
$66.81 |
$108,965 |
D/D |
(1,631) |
66,954 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Business & Strat Officer |
• • – |
2023-10-23 |
4 |
S |
$46.04 |
$6,031 |
D/D |
(131) |
51,622 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Business & Strat Officer |
• – – |
2023-02-21 |
4 |
D |
$58.50 |
$25,799 |
D/D |
(441) |
51,341 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Business & Strat Officer |
• – – |
2023-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,280 |
51,782 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Business & Strat Officer |
• • – |
2023-02-10 |
4 |
D |
$51.21 |
$34,311 |
D/D |
(670) |
46,502 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Business & Strat Officer |
• • – |
2023-01-27 |
4 |
D |
$52.77 |
$19,367 |
D/D |
(367) |
47,172 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Business & Strat Officer |
• • – |
2023-01-20 |
4 |
D |
$52.05 |
$59,805 |
D/D |
(1,149) |
47,539 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Business & Strat Officer |
• • – |
2023-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
19,634 |
48,688 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-10-20 |
4 |
D |
$58.00 |
$11,368 |
D/D |
(196) |
29,054 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-08-17 |
4 |
AS |
$69.50 |
$347,500 |
D/D |
(5,000) |
29,250 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-08-17 |
4 |
OE |
$15.52 |
$77,600 |
D/D |
5,000 |
34,250 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-08-11 |
4 |
OE |
$15.52 |
$77,600 |
D/D |
5,000 |
34,250 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-08-11 |
4 |
AS |
$67.00 |
$335,000 |
D/D |
(5,000) |
29,250 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-08-08 |
4 |
AS |
$64.50 |
$322,500 |
D/D |
(5,000) |
29,250 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-08-08 |
4 |
OE |
$15.52 |
$77,600 |
D/D |
5,000 |
34,250 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-08-04 |
4 |
AS |
$59.50 |
$607,500 |
D/D |
(10,000) |
29,250 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-08-04 |
4 |
OE |
$15.52 |
$155,200 |
D/D |
10,000 |
39,250 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-07-27 |
4 |
AS |
$57.00 |
$285,000 |
D/D |
(5,000) |
29,250 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-07-27 |
4 |
OE |
$15.52 |
$77,600 |
D/D |
5,000 |
34,250 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Senior Vice President |
• • – |
2022-07-19 |
4 |
AS |
$56.42 |
$282,100 |
D/D |
(5,000) |
29,250 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
